Research & Development News

Scientists have found a modified poliovirus vaccine may be beneficial for treating recurrent glioblastoma

Targeting drug therapies at Dkk1 functioning could limit arteriosclerotic disease, researchers say

The thyroid hormone has proved effective in treating symptoms present in rats.

L-methylfolate could help patients who do not respond to selective serotonin reuptake inhibitor antidepressants.

Bazedoxifene's effects on oestrogen mean it may protect against both osteoporosis and breast cancer.

ACY-1215 inhibits the enzyme HDAC6 in order to encourage apoptosis in multiple myeloma cells.

A new report indicates that clinical trial costs are closely tied to patient enrollment.

The inhaler delivers insulin to type 2 diabetes patients prior to a meal to prevent hyperglycemia.

The drug could treat people with cardiopulmonary disease.

A clinical trial examining how to destroy cancerous stem cells is to get underway.

The drug may prevent metastasis by inhibiting the migratory processes in epithelial cells.

The drug could deliver higher doses of doxorubicin without the same levels of toxicity.

Medivation and Astellas Pharma have announced Phase 2 of TNBC trials.

InGeneron is looking to see how effective the utilisation of regenerative cells from a patient can be in healing a knee cartilage.

A study at the Hospital For Special Surgery has shown progress towards methods to better target drugs

A deal has been reached between Nerviano and Servier for a novel anticancer drug.

Grants will be provided to Altravax so it can research vaccines for dengue virus and chronic hepatitis B.

A topical spray for psoriasis has been approved for a new drug application.

New partnership could pave the way for previously undiscovered cures

De novo mutations in the developing heart may be the cause of congential heart disease

Researchers may have identified two non-toxic alternatives to acetaminophen.

The EMA has approved Votrient following the publication of positive clinical trial results.

Ben Goldacre is calling for full disclosure of clinical trial results.

The surgical device helps seal tonsillectomy wounds in order to speed up the recovery process.

The reports help investors and manufacturers to estimate the cost of a study.

A team of researchers say removing benign tumours in the adrenal glands could cure high blood pressure.

Ultrasound can be used to prevent acute kidney injury following surgery.

Clinical outcomes of ABA and ADA treatments were comparable in an RA patient cohort.

The drug could prove effective in populations of patients intolerant to statins.

Centara has upgraded its SYBYL-X drug development software suite.

The treatment may help to reduce immune system myelin resistance by up to 75 per cent.

Laboratory mice responded positively to Oprl1, and the next step is to determine its effect on humans.

Scientists have developed a compound that could both kill melanoma cells and prevent metastasis.

The Next Wave approach improved patients' total field of vision by 24 per cent.

The muscle relaxant will serve as an alternative in territories where Galderma cannot distribute Azzalure or Dysport.

The company will purchase Elan's 50 per cent stake in the commercial and strategic.

Could stem cell treatment be the way to improve outcomes for stroke patients?

Research has suggested a synthesised small molecule could be used to prevent the growth of prostate cancer cells

Research has discovered retigabine may prevent noise-induced tinnitus

Scientists have made a discovery that could lead to new therapies for rheumatoid arthritis

A novel anti-angiogenic peptide has been licensed to a South Korean firm for clinical development

Researchers have found that reducing SGK1 levels can help with the treatment of depression

An antibody may be used to treat multiple myeloma

An engineered protein has the potential to be used as an anti-venom vaccine

A team of researchers have developed a complete genetic profile of acute myeloid leukemia

A combination treatment has been shown to have a high viral cure rate among certain hepatitis C patients

A new ultrasound system has been announced

A novel anti-angiogenic peptide has been licensed to a South Korean firm for clinical development

Video microscopy has been used to identify why a cancer treatment is so effective.

An after-surgery adhesion could be used for the treatment of fibrosis.

Nice has suggested a treatment for advanced ovarian cancer is not worth the cost.

A phase II clinical trial will continue to test the effectiveness of a new drug for multiple myeloma.

A combination therapy for cystic fibrosis will now progress to a phase III study.

A new treatment for non-melanoma skin cancer has been highlighted at an annual meeting.

T2 Biosystems has announced progress in its hemostasis. product development program

A new drug has been shown to be potentially effective for the treatment of schizophrenia.

A clinical trial is testing how well Paxa-Vec could act on liver cancer.

Chemists have found that marine algae may be used to increase oil production

A Danish study has found Brintellix could be an effective treatment for those with MDD.

Clinical trials have revealed that chemotherapy and surgery 'boosts survival' in advanced gastric cancer.

Theraclone Sciences announces CMV trial results

Theraclone Sciences announces CMV trial results

Alnylam is working with the Medicines Company to commercialise its hypercholesterolemia treatment.

Respiratory tract vaccine trial a success, Novavax indicates.

The latest report from business intelligence firm Cutting Edge Information highlights the importance of planning carefully ahead of the initiation of phase-I trials.

Chugai has been given the go-ahead to start clinical trials of its new arthritis treatment in Japan

NTDs are acknowledged to be a major global problem.

The company will use clinical data management services from Medidata Solutions.

The Mayo Clinic will be involved in Phase II trials for a new ALS treatment.

CoCo Therapeutics is a joint project between King's College London, The Wellcome Trust and Advent Venture Partners.

A new pharmaceutical gel has been developed that is capable of releasing drugs when pressure is applied by the patient.

Sistemic and Leading CDMO, Progenitor Cell Therapy (PCT) Initiate Study on Novel Stem Cell Characterisation Technology

Comprehensive, biomarker-based patient profiling will help risk stratification, improve trial efficacy and provide biomarker driven insight regarding patient targeting and potential outcomes

The HyBeacons PCR probe technology will be used in the development of diagnostic tests for infectious diseases.

RegeneCure announced the successful results of a clinical study in pets

A study shows the number of sites required for an oncology clinical trial is dependent on the total patients needed.

King’s College London, The Wellcome Trust and Advent Venture Partners today announced the formation of a new UK biotechnology company.

Research focus on investigation of laminin-based approaches

Cylene Pharmaceuticals is handing off its Phase II compound Quarfloxin and associated anticancer quadruplex-targeting technologies to oncology drug discovery and development company TetraGene

Two impending clinical trials will look at plaque psoriasis treatment.

pSivida has announced that Phase III clinical trials for uveitis treatment are now underway.

TransTech Pharma is looking forward to undertaking Phase III clinical trials to examine how effective TTP488 can be in the treatment of Alzheimer's disease.

Bioline Coating with Recombumin Alpha has been approved for use in Japan.

Company is developing pre-optimized HCP assay kits

A new iron supplement for women has been unveiled by US firm Avion Pharmaceuticals.

WCCT has developed a new tool to help recruit patients to clinical trials.

Cytori Therapeutics' new reagent for use when administering intravascular stem cells to patients has received a CE Mark of approval in Europe.

India-based CRO GVK Biosciences will develop small molecules for Endo.

Tracera promises to detect organic and inorganic trace compounds at the sub parts per million level.

Hydrix from Carnegie is now looking at tapping opportunities in technology transfer and joint product development for range of point-of-care (POC) diagnostics with companies in India.The company is a mobile-wireless technology major and an award winner...

Affordable treatment for the common man should be the focus of any drug development and the important aspect to be considered while engaging in the discovery of drugs is the effective cure for diseases.

The FDA has approved Lantheus Medical's use of its JHS site for manufacturing of the ultrasound imaging agent Definitny Vial.